✦ LIBER ✦

Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemia

✍ Scribed by Susan O'Brien; David A. Rizzieri; Norbert Vey; Farhad Ravandi; Utz O. Krug; Mikkael A. Sekeres; Mike Dennis; Adriano Venditti; Donald A. Berry; Tove Flem Jacobsen; Karin Staudacher; Trygve Bergeland; Francis J. Giles

Book ID: 117946784
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 157 KB
Volume: 158
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2012.09186.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lymphocyte activation in patients with a

Lymphocyte activation in patients with acute myeloid leukaemia Evidence for the presence of myeloblast antigen?

✍ Seah H. Lim; Colin P. Worman; Anthony H. Goldstone 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 500 KB

Treatment of acute myeloid leukemia in e

Treatment of acute myeloid leukemia in elderly patients with oral idarubicin as a single agent

✍ J. L. Harousseau; F. Rigal-Huguet; P. Hurteloup; H. Guy; N. Milpied; J. Pris 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB

Effect of gemtuzumab ozogamicin on acute

Effect of gemtuzumab ozogamicin on acute myeloid leukaemia blast cells in vitro, as a single agent and combined with other cytotoxic agents

✍ K. L. Morris; J. A. Adams; J. A. Liu Yin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

Effect of cloretazine (VNP40101M) on acu

Effect of cloretazine (VNP40101M) on acute myeloid leukaemia blast cells in vitro as a single agent and combined with cytarabine and daunorubicin

✍ Karen L. Morris; Julie A. Adams; John A. Liu Yin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 612 KB

We have investigated the effect of cloretazine (VNP40101M or Laromustine), a novel sulfonylhydrazine alkylating agent with significant antileukaemic activity, alone, or combined with cytarabine or daunorubicin, on the proliferation, viability and apoptosis of cell lines and acute myeloid leukaemia b

Successful induction of molecular remiss

Successful induction of molecular remission with single-agent anti-CD33 antibody (gemtuzumab ozogamicin) in chemotherapy-refractory relapse of acute myeloid leukaemia post-BMT

✍ R. Swords; P. J. Hayden; K. Molloy; M. Lawlor; P. V. Browne; P. T. Murphy 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

A single apheresis to achieve a high num

A single apheresis to achieve a high number of peripheral blood CD34+ cells in a lithium-treated patient with acute myeloid leukaemia

✍ Canales, M A; Arrieta, R; Hernández-García, C; Bustos, JGa; Aguado, MaJ; Hernánd 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 21 KB